Clinical Trial Update: Trial to Optimally Show the Pharmacological Action of Z-100 [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the pharmacological action of Z-100 for cervical cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Z-100

Snippet

Sponsor: Zeria Pharmaceutical | Conditions: Cervical Cancer | Phase 3 | Status: COMPLETED